Incannex Healthcare Limited — Form 6-K Summary
Business context and reporting period
Incannex Healthcare Limited, an Australian foreign private issuer, filed this Form 6-K on June 7, 2023, covering the month of June 2023. The filing reports that the company submitted an Australian Securities Exchange announcement on June 6, 2023, titled “Change of Director’s Interest Notice.”
Financial and operating metrics
The filing text does not provide revenue, profit, cash flow, margins, debt, liquidity, operating results, or other financial metrics.
Material changes versus the prior comparable period
The filing describes a change in a director’s interest, but the text provided does not include the attached Exhibit 99.1 details. Accordingly, the identity of the director, the securities involved, the nature of the change, and the transaction amounts are not clear from this filing text.
Guidance, outlook, risks, and unusual items
No guidance, forecast, management outlook, risk update, contingency, or unusual financial item is disclosed in the provided Form 6-K text. The filing incorporates the ASX announcement as Exhibit 99.1, but its contents are not included.
Important facts for investors to verify
- Obtain and review Exhibit 99.1, the June 6, 2023 ASX “Change of Director’s Interest Notice.”
- Verify which director’s interest changed and whether the change involved acquisitions, disposals, transfers, or other dealings.
- Confirm the number and class of securities affected, transaction dates, prices, and resulting holdings.
- Review subsequent filings for any additional director-interest changes or related-party disclosures.